Delighted to share the launch of the Cambridge-led, £50m MRC Centre of Research Excellence in Mitochondrial Genome Therapeutics (CoRE-MitoGT). Over 14 years, we will unite international expertise to understand mtDNA disease & develop therapies targeting its root causes. www.ukri.org/news/mrc-fun...
MRC funds world-class research into fatal genetic diseases
The Medical Research Council (MRC) has invested £50 million into the study of mitochondrial diseases to improve treatments.
ukri.org